Emergent Biosolutions Stock Technical Analysis
| EBS Stock | USD 10.83 0.02 0.18% |
As of the 17th of February 2026, Emergent Biosolutions shows the Coefficient Of Variation of 8040.46, mean deviation of 2.6, and Downside Deviation of 3.74. Emergent Biosolutions technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Emergent Biosolutions variance, as well as the relationship between the value at risk and skewness to decide if Emergent Biosolutions is priced favorably, providing market reflects its regular price of 10.83 per share. Given that Emergent Biosolutions has jensen alpha of (0.06), we urge you to verify Emergent Biosolutions's prevailing market performance to make sure the company can sustain itself at a future point.
Emergent Biosolutions Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Emergent, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to EmergentEmergent Biosolutions' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Emergent Biosolutions Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 13.5 | Buy | 3 | Odds |
Most Emergent analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Emergent stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Emergent Biosolutions, talking to its executives and customers, or listening to Emergent conference calls.
Is there potential for Biotechnology market expansion? Will Emergent introduce new products? Factors like these will boost the valuation of Emergent Biosolutions. Projected growth potential of Emergent fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Emergent Biosolutions listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.56) | Earnings Share 1.32 | Revenue Per Share | Quarterly Revenue Growth (0.21) | Return On Assets |
Emergent Biosolutions's market price often diverges from its book value, the accounting figure shown on Emergent's balance sheet. Smart investors calculate Emergent Biosolutions' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Emergent Biosolutions' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Emergent Biosolutions' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Emergent Biosolutions should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Emergent Biosolutions' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Emergent Biosolutions 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Emergent Biosolutions' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Emergent Biosolutions.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in Emergent Biosolutions on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding Emergent Biosolutions or generate 0.0% return on investment in Emergent Biosolutions over 90 days. Emergent Biosolutions is related to or competes with SIGA Technologies, SNDL, Esperion Therapeutics, Aquestive Therapeutics, Rigel Pharmaceuticals, Organogenesis Holdings, and Prothena Plc. Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions tha... More
Emergent Biosolutions Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Emergent Biosolutions' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Emergent Biosolutions upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.74 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 23.25 | |||
| Value At Risk | (4.71) | |||
| Potential Upside | 6.91 |
Emergent Biosolutions Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Emergent Biosolutions' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Emergent Biosolutions' standard deviation. In reality, there are many statistical measures that can use Emergent Biosolutions historical prices to predict the future Emergent Biosolutions' volatility.| Risk Adjusted Performance | 0.0179 | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.24) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0234 |
Emergent Biosolutions February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0179 | |||
| Market Risk Adjusted Performance | 0.0334 | |||
| Mean Deviation | 2.6 | |||
| Semi Deviation | 3.67 | |||
| Downside Deviation | 3.74 | |||
| Coefficient Of Variation | 8040.46 | |||
| Standard Deviation | 3.71 | |||
| Variance | 13.79 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.24) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0234 | |||
| Maximum Drawdown | 23.25 | |||
| Value At Risk | (4.71) | |||
| Potential Upside | 6.91 | |||
| Downside Variance | 13.97 | |||
| Semi Variance | 13.5 | |||
| Expected Short fall | (2.73) | |||
| Skewness | (0.18) | |||
| Kurtosis | 2.29 |
Emergent Biosolutions Backtested Returns
Emergent Biosolutions appears to be somewhat reliable, given 3 months investment horizon. Emergent Biosolutions secures Sharpe Ratio (or Efficiency) of 0.0586, which denotes the company had a 0.0586 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Emergent Biosolutions, which you can use to evaluate the volatility of the firm. Please utilize Emergent Biosolutions' Downside Deviation of 3.74, mean deviation of 2.6, and Coefficient Of Variation of 8040.46 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Emergent Biosolutions holds a performance score of 4. The firm shows a Beta (market volatility) of 1.55, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Emergent Biosolutions will likely underperform. Please check Emergent Biosolutions' value at risk, and the relationship between the jensen alpha and skewness , to make a quick decision on whether Emergent Biosolutions' price patterns will revert.
Auto-correlation | -0.81 |
Excellent reverse predictability
Emergent Biosolutions has excellent reverse predictability. Overlapping area represents the amount of predictability between Emergent Biosolutions time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Emergent Biosolutions price movement. The serial correlation of -0.81 indicates that around 81.0% of current Emergent Biosolutions price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.81 | |
| Spearman Rank Test | -0.74 | |
| Residual Average | 0.0 | |
| Price Variance | 0.72 |
Emergent Biosolutions technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Emergent Biosolutions Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Emergent Biosolutions volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Emergent Biosolutions Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Emergent Biosolutions on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Emergent Biosolutions based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Emergent Biosolutions price pattern first instead of the macroeconomic environment surrounding Emergent Biosolutions. By analyzing Emergent Biosolutions's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Emergent Biosolutions's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Emergent Biosolutions specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 6.14 | 10.97 | 9.87 | 10.37 | Days Of Inventory On Hand | 174.16 | 170.26 | 195.8 | 170.63 |
Emergent Biosolutions February 17, 2026 Technical Indicators
Most technical analysis of Emergent help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Emergent from various momentum indicators to cycle indicators. When you analyze Emergent charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0179 | |||
| Market Risk Adjusted Performance | 0.0334 | |||
| Mean Deviation | 2.6 | |||
| Semi Deviation | 3.67 | |||
| Downside Deviation | 3.74 | |||
| Coefficient Of Variation | 8040.46 | |||
| Standard Deviation | 3.71 | |||
| Variance | 13.79 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.24) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0234 | |||
| Maximum Drawdown | 23.25 | |||
| Value At Risk | (4.71) | |||
| Potential Upside | 6.91 | |||
| Downside Variance | 13.97 | |||
| Semi Variance | 13.5 | |||
| Expected Short fall | (2.73) | |||
| Skewness | (0.18) | |||
| Kurtosis | 2.29 |
Emergent Biosolutions February 17, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Emergent stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.04 | ||
| Daily Balance Of Power | (0.04) | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 10.99 | ||
| Day Typical Price | 10.94 | ||
| Price Action Indicator | (0.17) | ||
| Market Facilitation Index | 0.50 |
Additional Tools for Emergent Stock Analysis
When running Emergent Biosolutions' price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.